MétaCan
Menu
← Back to cohort
Record W4406223549 · doi:10.1002/alz.093782

The prevalence of tau‐PET positivity in aging and dementia

2024· article· en· W4406223549 on OpenAlexaff
Emma M. Coomans, Colin Groot, Christopher C. Rowe, Vincent Doré, Victor L. Villemagne, Elsmarieke van de Giessen, Wiesje M. van der Flier, Yolande A.L. Pijnenburg, Pieter Jelle Visser, Anouk den Braber, Michael J. Pontecorvo, Sergey Shcherbinin, Ian Kennedy, William J. Jagust, Suzanne L. Baker, Theresa M. Harrison, Juan Domingo Gispert, Mahnaz Shekari, Carolina Minguillón, Ruben Smith, Niklas Mattsson, Sebastian Palmqvist, Olof Strandberg, Erik Stomrud, Maura Malpetti, John T. O’Brien, James B. Rowe, Elena Jäger, Gérard N. Bischof, Alexander Drzezga, Valentina Garibotto, Giovanni B. Frisoni, Débora Elisa Peretti, Michael Schöll, Ingmar Skoog, Silke Kern, Reisa A. Sperling, Keith A. Johnson, Shannon L. Risacher, Andrew J. Saykin, María C. Carrillo, Brad C. Dickerson, Liana G. Apostolova, Henryk Barthel, Michael Rullmann, Konstantin Messerschmidt, Rik Vandenberghe, Koen Van Laere, Laure Spruyt, Nicolai Franzmeier, Matthias Brendel, Johannes Gnörich, Tammie L.S. Benzinger, Julien Lagarde, Marie Sarazin, Michel Bottlaender, Sylvia Villeneuve, Judes Poirier, Sang Won Seo, Yuna Gu, Jun Pyo Kim, Elizabeth C. Mormino, Christina B. Young, Hillary Vossler, Pedro Rosa‐Neto, Joseph Therriault, Nesrine Rahmouni, William Coath, David M. Cash, Jonathan M. Schott, Gil D. Rabinovici, Renaud La Joie, Howard J. Rosen, Sterling C. Johnson, Bradley Christian, Tobey J. Betthauser, Oskar Hansson, Rik Ossenkoppele

Bibliographic record

VenueAlzheimer s & Dementia · 2024
Typearticle
Languageen
FieldMedicine
TopicDiet and metabolism studies
Canadian institutionsMcGill UniversityDouglas Mental Health University Institute
Fundersnot available
KeywordsDementiaPsychologyGerontologyMedicineNeuroscienceInternal medicineDisease

Abstract

fetched live from OpenAlex

Abstract Background Tau‐PET imaging allows in‐vivo detection of neurofibrillary tangles. One tau‐PET tracer (i.e., [18F]flortaucipir) has received FDA‐approval for clinical use, and multiple other tau‐PET tracers have been implemented into clinical trials for participant selection and/or as a primary or secondary outcome measure. To optimize future use of tau‐PET, it is essential to understand how demographic, clinical and genetic factors affect tau‐PET‐positivity rates. Method This large‐scale multi‐center study includes 9713 participants from 35 cohorts worldwide who underwent tau‐PET with [18F]flortaucipir (n = 6420), [18F]RO948 (n = 1999), [18F]MK6240 (n = 878) or [18F]PI2620 (n = 416) (Table‐1). We analyzed individual‐level tau‐PET SUVR data using a cerebellar reference region that were processed either centrally (n = 3855) or by each cohort (n = 5858). We computed cohort‐specific SUVR thresholds based on the mean + 2 standard deviations in a temporal meta‐region of amyloid‐negative cognitively normal (CN) individuals aged >50. Logistic generalized estimating equations were used to estimate tau‐PET‐positivity probabilities, using an exchangeable correlation structure to account for within‐cohort correlations. Analyses were performed with (interactions between) age, amyloid‐status, and APOE‐e4 carriership as independent variables, stratified for syndrome diagnosis. Result The study included 5962 CN participants (7.5% tau‐PET‐positive), 1683 participants with mild cognitive impairment (MCI, 33.8% tau‐PET‐positive) and 2068 participants with a clinical diagnosis of dementia (62.1% tau‐PET‐positive) (Figure‐1). From age 60 to 80 years, the estimated prevalence of tau‐PET‐positivity increased from 1.2% [95% CI: 0.9%‐1.5%] to 3.7% [2.3%‐5.1%] among CN amyloid‐negative participants; and from 16.4% [10.8%‐22.1%] to 20.5% [18.8%‐22.2%] among CN amyloid‐positive participants. Among amyloid‐negative participants with MCI and dementia, from age 60 to 80 years, the estimated prevalence of tau‐PET‐positivity increased from 3.5% [1.6%‐5.3%] to 11.8% [7.1%‐16.5%] and from 12.6% [4.5%‐20.7%] to 15.9% [6.7%‐25.1%] respectively. In contrast, among amyloid‐positive participants with MCI and dementia, from age 60 to 80 years, the estimated prevalence of tau‐PET‐positivity decreased from 66.5% [57.0%‐76.0%] to 48.3% [42.9%‐53.8%] and from 92.3% [88.7%‐95.9%] to 73.4% [67.5%‐79.3%] respectively. APOE‐e4 status primarily modulated the association of age with tau‐PET‐positivity estimates among CN and MCI amyloid‐positive participants (Figure‐2). Conclusion This large‐scale multi‐cohort study provides robust prevalence estimates of tau‐PET‐positivity, which can aid the interpretation of tau‐PET in the clinic and inform clinical trial designs.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.006
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.014

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.006
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0020.001
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0000.000
Research integrity0.0010.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.019
GPT teacher head0.289
Teacher spread0.269 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & Dementia→Same topicDiet and metabolism studies→French-language works237,207→